Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gene editing
Pharma
Agilent will pay $925M to acquire specialty CDMO Biovectra
After changing hands several times throughout the 2010s, Canadian specialty CDMO Biovectra has agreed to fly the Agilent flag.
Fraiser Kansteiner
Jul 22, 2024 11:01am
'The Top Line': Gene editing's next act
Feb 16, 2024 8:55am
Vertex forecasts 'foundational year' for CRISPR gene therapy
Nov 7, 2023 8:40am
Vertex, bluebird SCD gene therapies can cost $1.9M: ICER
Apr 13, 2023 11:33am
Vertex teases launch plans for first CRISPR gene editing therapy
Feb 8, 2023 2:55pm
